New Promising Therapeutic Applications of Curcumin: Outcome and Pathways

Dear Colleagues,

Plants and their constituents have been incredibly popular in health management since antiquity. Numerous in vitro and in vivo studies have shown the beneficial effects of medicinal plants in different diseases through the modulation of cellular response, cell signaling, and epigenetic processes. Polyphenols such as resveratrol, curcumin, flavonoids, etc. are involved in plants’ defensive response against stress from ultraviolet radiation, pathogen agents, and physical damage.

Curcumin is a natural dietary polyphenol extracted from Curcuma Longa L. that exhibits a number of health proprieties, including antibacterial, antiviral, anticancer, anti-inflammatory, antioxidant, and antiaging properties.

Curcumin is a highly pleiotropic molecule that interacts with numerous molecular targets, including miRNA, and is used for the treatment of neurodegenerative, atherosclerosis, cardiovascular, cancer, pulmonary, autoimmune and neoplastic diseases, biliary and hepatic disorders, metabolic diseases, wound healing, rheumatoid arthritis, chronic inflammation, chronic kidney diseases, hypertension, osteoporosis, and ocular and skin diseases.

Curcumin bioavailability is very low in humans, so an appropriate nanocarrier-mediate delivery system may increase its therapeutic index.

This Special Issue entitled “New Promising Therapeutic Applications of Curcumin: Outcome and Pathways” welcomes the submission of both original research manuscripts and reviews concerning the biological effects of curcumin in vitro, its bioavailability, and its health-promoting effects other than its potential therapeutic applications, including its incorporation into novel functional matrices.

Prof. Dr. Chiara Porro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.